Ghanemi Abdelaziz, Mac-Way Fabrice
Endocrinology and Nephrology Axis, L'Hôtel-Dieu de Québec Hospital, CHU de Québec Research Center, Quebec, QC G1R 2J6, Canada.
Department of Medicine, Faculty of Medicine, Laval University, Quebec, QC G1V 0A6, Canada.
Life (Basel). 2023 Nov 6;13(11):2172. doi: 10.3390/life13112172.
Obesity is a health condition that represents a risk factor for numerous diseases and complications. However, obesity might also have-to some extent-some "benefits" in certain situations. This includes potential bone protection in patients suffering from chronic kidney disease. In an attempt to explain such a paradox, we highlight secreted protein acidic and rich in cysteine (SPARC) as a hypothetical mediator of this protection. Indeed, SPARC properties provide a logical rationale to describe such bone protection via its overexpression combined with its calcium-binding and collagen-binding properties. We believe that exploring such hypotheses could open new doors to elucidate unknown pathways towards developing a new generation of molecular therapies.
肥胖是一种健康状况,是许多疾病和并发症的风险因素。然而,肥胖在某些情况下在一定程度上可能也有一些“益处”。这包括对慢性肾病患者的潜在骨骼保护作用。为了解释这一矛盾现象,我们强调富含半胱氨酸的酸性分泌蛋白(SPARC)是这种保护作用的一种假设介导因子。事实上,SPARC的特性通过其过表达以及钙结合和胶原结合特性为描述这种骨骼保护作用提供了合理的理论依据。我们认为,探索此类假设可能会为阐明未知途径打开新的大门,从而开发新一代分子疗法。